Clinical Trials · NCT01420250
Cabazitaxel With Radiation and Hormone Therapy for Prostate Cancer
- Phase
- Phase 1
- Recruitment status
- Completed
- Sponsor
- Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University
- Enrollment
- 20
- Start date
- Sep 2011
- Locations
- 1 site, United States
- Primary endpoint
- Maximally Tolerated Dose (MTD) of Cabazitaxel and Intensity Modulated Radiation Therapy (IMRT)